The study by Sharma et al. on tumor and serum samples from 100 patients with invasive ductal breast carcinoma (IDC) has investigated the potential of the ABCB1 promoter methylation status as predictive or prognostic marker in breast cancer [152]. Here, ABCB1 is linked to breast carcinoma.